Frontlight ResearchEarly access
Trial site
Shiyan Renmin Hospital
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Psoriasis3 trials
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Rheumatoid arthritis1 trial
- Stroke1 trial
- Phase
- Phase 24 trials
- Phase 33 trials
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 trial
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.1 trial
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 trial
- and 1 more
Running trials
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Active, not recruiting
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer1 recruiting
Closed trials
Terminated
Completed
Completed
Terminated
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis
Site data: ClinicalTrials.govUpdated 12 Nov 2026